Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Mitochondrion|May 4, 2010
Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transitionAna T Varela, Anabela M Simões, João S Teodoro, et al.
Toxicology and Applied Pharmacology|September 13, 2008
Indirubin-3'-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition inductionAna T Varela, Ana P Gomes, Anabela M Simões, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 15, 2011
Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspectiveJoão S Teodoro, Anabela M Simões, Filipe V Duarte, et al.
FEBS Letters|November 19, 2003
Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic ratsPaulo J Oliveira, Raquel Seiça, Pedro M Coxito, et al.
Redox Biology|September 5, 2015
Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?Agnes Görlach, Elitsa Y Dimova, Andreas Petry, et al.
International Journal of Molecular Sciences|February 15, 2022
PEG35 as a Preconditioning Agent against Hypoxia/Reoxygenation InjuryRui Teixeira da Silva, Ivo F Machado, João S Teodoro, et al.
Cells|February 25, 2022
Shaping of Hepatic Ischemia/Reperfusion Events: The Crucial Role of MitochondriaJoão S Teodoro, Rui T Da Silva, Ivo F Machado, et al.
Cell Death Discovery|January 23, 2018
Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liver injuryAlberto Rossetti, Gabriele Togliatto, Anabela P Rolo, et al.
International Journal of Molecular Sciences|November 13, 2021
Chenodeoxycholic Acid Has Non-Thermogenic, Mitodynamic Anti-Obesity Effects in an In Vitro CRISPR/Cas9 Model of Bile Acid Receptor TGR5 KnockdownJoão S Teodoro, Ivo F Machado, Ana C Castela, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|January 12, 2005
Advantages in the use of carvedilol versus propranolol for the protection of cardiac mitochondrial functionPaulo J Oliveira, Anabela P Rolo, Vilma A Sardão, et al.
Pageof 8